Skip to content

Partial Lateral Internal Sphincterotomy Versus Combined Botulinum Toxin A Injection and Topical Application of Diltiazem in Treatment of Chronic Anal Fissure

Partial Lateral Internal Sphincterotomy Versus Combined Botulinum Toxin A Injection and Topical Application of Diltiazem in treatment of chronic anal fissure

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013042812294N3
Enrollment
99
Registered
2013-10-21
Start date
2010-03-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Anal Fissure. Chronic Anal Fissure

Interventions

Intervention 1: Intervention group: Under local anesthesia (with lidocaine 5% gel) on left sided or knee elbow position. BTA is injected into the internal anal sphincter on the both sides of anterior
internal sphincter muscle fibers were partially cut at 3 o’clock position under direct visualization with a transverse incision up to the height of the fissure apex using a cautery. In this study, s
Treatment - Drugs
Treatment - Surgery
Intervention group: Under local anesthesia (with lidocaine 5% gel) on left sided or knee elbow position. BTA is injected into the internal anal sphincter on the both sides of anterior midline in equal
Control group: under spinal anesthesia in the lithotomy position
internal sphincter muscle fibers were partially cut at 3 o’clock position under direct visualization with a transverse incision up to the height of the fissure apex using a cautery. In this study,

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: diagnosis of chronic anal fissure on physical examination (based on having indurations at the edges and having at least two criteria of these three including skin tag; hypertrophied anal papillae and exposed internal sphincter muscle fiber) by an experienced colorectal surgeon associated with painful defecation for at least 2 month; age between 18 and 100 years old. Exclusion criteria: acute anal fissure (experiencing symptoms less than two months); pregnancy; secondary anal fissure; hypersensitivity to DTZ or BTA; cardiovascular disease; previous history of anal surgery; atypical fissure and chronic headache.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Wound healing. Timepoint: one week, 1,2,6 and 12 months postoperatively. Method of measurement: Complete Wound Healing (macroscopic epithelialization).

Secondary

MeasureTime frame
Complications. Timepoint: , one week, 1,2,6,12 months postoperatively. Method of measurement: physical examination and history taking, VAS.;Induration, hypertrophied papilla, exposing internal anal sphincter,skin tag. Timepoint: before and after surgery. Method of measurement: physical examination.;Pain. Timepoint: before treatment, 1 week, 1,2,6 and 12 months postoperatively. Method of measurement: visual analog scale.;Chronicity of fissure. Timepoint: before treatment. Method of measurement: history taking.;Fissure localization. Timepoint: before treatment. Method of measurement: physical examination.;Bleeding. Timepoint: before treatment, 1 week, 1,2,6 and 12 months postoperatively. Method of measurement: history taking.;Pain at night. Timepoint: before treatment, 1 week, 1,2,6 and 12 months postoperatively. Method of measurement: history taking.;Recurrence. Timepoint: 1 ,2,6 and 12 month postoperatively. Method of measurement: history taking and physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Heydari

Tehran University of Medical Sciences, Medical School

heidari.reza1@yahoo.com00

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026